Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action

Erika N Cline1, Ming-Hsin Li, Seok Ki Choi

  • 1Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA.

Biomacromolecules
|February 9, 2013
PubMed

Insights

Paclitaxel-conjugated dendrimers stabilize microtubules, enhancing anticancer effects. However, they also bundle microtubules independently of paclitaxel, posing potential therapeutic risks.

Area of Science:

  • Biochemistry
  • Nanotechnology
  • Pharmacology

Background:

  • Paclitaxel (Taxol) is an effective anticancer drug that stabilizes microtubules, but its hydrophobicity causes side effects.
  • Paclitaxel-conjugated polyamidoamine (PAMAM) dendrimers offer targeted delivery and cytotoxicity in cancer cells.
  • The precise mechanisms underlying the cytotoxicity of these conjugates remain unclear.

Purpose of the Study:

  • To investigate the mechanism of action for paclitaxel-conjugated PAMAM dendrimers.
  • To determine if conjugated paclitaxel can bind and affect microtubules.
  • To elucidate whether cytotoxicity is due to microtubule stabilization or other factors.

Main Methods:

  • In vitro studies utilizing ensemble and single microtubule imaging techniques.
  • Analysis of microtubule polymerization and bundling in the presence of paclitaxel-conjugated PAMAM dendrimers.

Main Results:

  • Paclitaxel-conjugated dendrimers promote microtubule polymerization and stabilization in a paclitaxel-dependent manner.
  • These conjugates also induce microtubule bundling independently of paclitaxel, possibly due to dendrimer protonation.
  • The findings suggest dual mechanisms affecting microtubule dynamics.

Conclusions:

  • Paclitaxel-conjugated PAMAM dendrimers exert cytotoxicity through paclitaxel-mediated microtubule stabilization.
  • An unexpected finding is the paclitaxel-independent microtubule bundling effect of the dendrimer itself.
  • These results highlight potential risks associated with using such dendrimer conjugates therapeutically.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Assembly of Complex Microtubule Structures01:32

Assembly of Complex Microtubule Structures

Complex microtubule structures are present in resting cells and in dividing cells. In resting cells, they are responsible for maintaining the cellular architecture, tracks for intracellular transport, positioning of organelles, assembly of cilia and flagella. They mediate the bipolar spindle assembly for chromosomal segregation and positioning of the cell division plate in dividing cells. The formation of microtubule complex structures depends on the cell type, cell stage, and cell function.